JN: "The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] NLMUID: 7513617" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
Autorzy :: Delaugerre C; Department of Virology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; INSERM U944, University of Paris, Paris, France.
Nere ML; Department of Virology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Eymard-Duvernay S; TransVIHMI, Institut de Recherche pour le Développement (IRD) - INSERM U1175 University of Montpellier, Montpellier, France.
Armero A; Department of Virology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Ciaffi L; TransVIHMI, Institut de Recherche pour le Développement (IRD) - INSERM U1175 University of Montpellier, Montpellier, France.
Koulla-Shiro S; Department of Infectious Diseases, Central Hospital Yaoundé, Yaoundé, Cameroon.
Sawadogo A; Day Care Center, University Hospital Souro Sanou, Bobo Dioulasso, Burkina Faso.
Ngom Gueye NF; Day Care Center, Fann University Hospital, Dakar, Senegal.
Ndour CT; Department of Infectious Diseases, Fann University Hospital, Dakar, Senegal.
Mpoudi Ngolle M; Ambulatory Treatment Center, Military Hospital Yaoundé, Yaoundé, Cameroon.
Amara A; INSERM U944, University of Paris, Paris, France.
Chaix ML; Department of Virology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; INSERM U944, University of Paris, Paris, France.
Reynes J; TransVIHMI, Institut de Recherche pour le Développement (IRD) - INSERM U1175 University of Montpellier, Montpellier, France.; Department of Infectious Diseases, Montpellier University Hospital, Montpellier, France.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 24. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?
Autorzy :: Portal E; Medical Microbiology, Department of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.; Bacteriology Reference Department, Public Health England, London, UK.
Descours G; Centre National de Reference des Legionelles, Hospices Civils de Lyon, University de Lyon, Lyon, France.
Ginevra C; Centre National de Reference des Legionelles, Hospices Civils de Lyon, University de Lyon, Lyon, France.
Mentasti M; Public Health Wales, Cardiff, UK.
Afshar B; Bacteriology Reference Department, Public Health England, London, UK.
Chand M; Bacteriology Reference Department, Public Health England, London, UK.
Day J; Bacteriology Reference Department, Public Health England, London, UK.
Echahidi F; Department of Microbiology and Infection Control, National Reference Centre for Legionella pneumophila, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Franzin L; Ospedale Amedeo di Savoia, Torino, Italy.
Gaia V; Department of Laboratory Medicine, Reference Centre for Legionella, Bellinzona, Switzerland.
Lück C; German Consiliary Laboratory for Legionella, Institute of Medical Microbiology and Hygiene, Dresden University of Technology, Dresden, Germany.
Meghraoui A; Department of Microbiology, National Reference Centre for Legionella pneumophila, Laboratoire Hospitalier Universitaire de Bruxelles-University Laboratory of Brussels (LHUB-ULB), Belgium.
Moran-Gilad J; Department of Health Systems Management, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Ricci ML; National Institute for Health, Rome, Italy.
Lina G; Centre National de Reference des Legionelles, Hospices Civils de Lyon, University de Lyon, Lyon, France.
Uldum S; Statens Serum Institute, Copenhagen, Denmark.
Winchell J; National Center for Immunization and Respiratory Diseases, Centres for Disease Control and Prevention, Atlanta, GA, USA.
Howe R; Public Health Wales, Cardiff, UK.
Bernard K; Special Bacteriology Unit, National Microbiology Laboratory-PHAC, Winnipeg, Canada.
Spiller OB; Medical Microbiology, Department of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
Chalker VJ; Bacteriology Reference Department, Public Health England, London, UK.; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Respiratory Infections at Imperial College London in partnership with Public Health England (PHE), London, UK.
Jarraud S; Centre National de Reference des Legionelles, Hospices Civils de Lyon, University de Lyon, Lyon, France.
Ahlen C
Hashmi IA
Allestam G
Amemura-Maekawa J
Andersson S
Bangsborg JM
Bararossa S
Beraud L
Bernard K
Borella P
Brandsema P
Bruin JP
Buzzigoli A
Cano R
Casini B
Celenza G
Chalker V
Collins S
Rotger SC
Cristina ML
Cristino S
David S
Jong B
Boer JD
Echahidi F
Elverdal PL
Erdogan H
Euser S
Franzin L
Fry NK
Gaia V
Garcia-Nuñez M
Ginevra C
Pasmal de Ameida Concalves EF
Gonçalves P
Fernandez TG
Grottola A
Gysin N
Harrison TG
Höfle M
Jarraud S
Jorgensen CS
Joseph C
Slott Kanto B
Kese D
Kindingstad L
Klingenberg DE
Kösekul M
Kozak-Muiznieks N
Kura F
Kusnetsov J
Lai S
Lee S
Lee JV
Lindsay D
Lück C
Leuscher M
der Lugt WV
Marques MT
Meacci M
Meghraoui A
Mentasti M
Mentula S
Mikrut A
Modol J
Moore G
Moran-Gilad J
Morin M
Otgun SN
Nataas OB
Abadi NN
Pancer K
Pecorari M
Pedro-Botet ML
Pelaz C
Petzold M
Pissarides N
Portal EAR
Ramliden M
Raphael B
Reddington K
Ricci ML
Robesyn E
Roisin S
Rumpianesi F
Saenz H
Scaturro M
Schalk J
Simone G
Bjerregaard SS
Spagnolo AM
Spiller OB
Aspelund AS
Svarrer CW
Tartakovshiy I
Templeton K
Uldum S
Veschetti E
Walker J
Wallet F
Wewalka G
Whapham C
Wunderlich A
Wybo I; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 20. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Expression of the qepA1 gene is induced under antibiotic exposure.
Autorzy :: Brandis G; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Box 582, Uppsala, Sweden.
Gockel J; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Box 582, Uppsala, Sweden.
Garoff L; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Box 582, Uppsala, Sweden.
Guy L; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Box 582, Uppsala, Sweden.
Hughes D; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Box 582, Uppsala, Sweden.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 20. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Aetiology of severe community-acquired pneumonia and antimicrobial susceptibility of Streptococcus pneumoniae in adults in Russia.
Autorzy :: Rachina S; Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Zakharenkov I; Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy, Smolensk, Russian Federation.
Dekhnich N; Smolensk State Medical University, Smolensk, Russian Federation.
Kozlov R; Smolensk State Medical University, Smolensk, Russian Federation.
Sinopalnikov A; Russian Medical Academy of Continuing Professional Education, Moscow, Russian Federation.
Ivanchik N; Smolensk State Medical University, Smolensk, Russian Federation.
Sukhorukova M; Smolensk State Medical University, Smolensk, Russian Federation.
Yatsyshina S; Central Research Institute for Epidemiology, Moscow, Russian Federation.
Arkhipenko M; Regional Clinical Hospital No. 1 n.a. Prof. S.V. Ochapovsky, Krasnodar, Russian Federation.
Gordeeva S; Regional Clinical Hospital n.a. P.A. Bayandin, Murmansk, Russian Federation.
Lebedeva M; Railway Clinical Hospital, Novosibirsk, Russian Federation.
Portnyagina U; North-Eastern Federal University n.a. M.K. Ammosov, Yakutsk, Russian Federation.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 19. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial.
Autorzy :: Brown JA; Swiss Tropical and Public Health Institute, Basel, Switzerland.; Molecular Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Amstutz A; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Nsakala BL; SolidarMed, Partnerships for Health, Maseru, Lesotho.
Seeburg U; Molecular Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Vanobberghen F; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Muhairwe J; SolidarMed, Partnerships for Health, Maseru, Lesotho.
Klimkait T; Molecular Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Daniel Labhardt N; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 18. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.
Autorzy :: Sprute R; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Salmanton-García J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Sal E; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Malaj X; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Ráčil Z; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.; Charles University, First Faculty of Medicine, Institute of Clinical and Experimental Hematology, Prague, Czech Republic.
Ruiz de Alegría Puig C; University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Falces-Romero I; Clinical Microbiology and Parasitology Department, La Paz University Hospital, Paseo de la Castellana 261, 28046, Madrid, Spain.
Barać A; Clinic for Infectious and Tropical Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Desoubeaux G; Department of Parasitology-Mycology-Tropical Medicine, Tours University hospital, France.
Kindo AJ; Department of Microbiology, SriRamachandra Institute of Higher Education and Research, Chennai, India.
Morris AJ; Clinical Microbiology Laboratory, LabPLUS, Auckland City Hospital, Auckland, 1023, New Zealand.
Pelletier R; Laboratoire de Microbiologie, L'Hôtel-Dieu de Québec du Centre Hospitalier Universitaire de Québec, Québec, Canada.
Steinmann J; Institute for Clinical Hygiene, Medical Microbiology and Clinical Infectiology, Paracelsus Medical University, Nuremberg Hospital, Nuremberg, Germany.
Thompson GR; Department of Internal Medicine Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, CA, USA.; Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento, CA, USA.
Cornely OA; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; University of Cologne, Faculty of Medicine, and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Seidel D; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Stemler J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 18. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: EUCAST rapid antimicrobial susceptibility testing (RAST): analytical performance and impact on patient management.
Autorzy :: Berinson B; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.
Olearo F; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.; Antibiotic Stewardship Team, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Both A; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.
Brossmann N; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.
Christner M; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.
Aepfelbacher M; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.
Rohde H; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 15. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK.
Autorzy :: Brown NM; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Brown EM; British Society for Antimicrobial Chemotherapy, Birmingham, UK.; Pokaż więcej
Corporate Authors :: Guideline Development Group
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 14. Date of Electronic Publication: 2021 Feb 14.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Efficacy of a novel lantibiotic, CMB001, against MRSA.
Autorzy :: Karczewski J; Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.
Brown CM; Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.
Maezato Y; Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.
Krasucki SP; Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.
Streatfield SJ; Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 14. Date of Electronic Publication: 2021 Feb 14.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Contribution of facility level factors to variation in antibiotic use in long-term care facilities: a national cohort study.
Autorzy :: Sluggett JK; University of South Australia, UniSA Allied Health and Human Performance, Adelaide, South Australia, Australia.; Registry of Senior Australians (ROSA), Healthy Ageing Research Consortium, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Moldovan M; Registry of Senior Australians (ROSA), Healthy Ageing Research Consortium, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Lang C; Registry of Senior Australians (ROSA), Healthy Ageing Research Consortium, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Lynn DJ; Precision Medicine Theme, South Australian Medical and Health Research Institute, Adelaide, South Australia, Australia.; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
Papanicolas LE; South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; The SAHMRI Microbiome Research Laboratory, School of Medicine, Flinders University, Bedford Park, South Australia, Australia.; Department of Infectious Diseases, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Crotty M; Department of Rehabilitation, Aged and Palliative Care, Flinders Medical Centre, Flinders University, Bedford Park, South Australia, Australia.
Whitehead C; Department of Rehabilitation, Aged and Palliative Care, Flinders Medical Centre, Flinders University, Bedford Park, South Australia, Australia.
Rogers GB; South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; The SAHMRI Microbiome Research Laboratory, School of Medicine, Flinders University, Bedford Park, South Australia, Australia.
Wesselingh SL; South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; The SAHMRI Microbiome Research Laboratory, School of Medicine, Flinders University, Bedford Park, South Australia, Australia.
Inacio MC; University of South Australia, UniSA Allied Health and Human Performance, Adelaide, South Australia, Australia.; Registry of Senior Australians (ROSA), Healthy Ageing Research Consortium, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 13. Date of Electronic Publication: 2021 Feb 13.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Practice- and individual-level antibiotic prescribing associated with antibiotic treatment non-response in respiratory tract infections: a national retrospective observational study.
Autorzy :: Peng Z; School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Hayen A; School of Public Health, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
Liu B; School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 804-812.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
Autorzy :: Salmerón P; Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Sexually Transmitted Infections Study Group (GEITS), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.; Department of Genetics and Microbiology, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Viñado B; Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
Arando M; Sexually Transmitted Infections Study Group (GEITS), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.; Drassanes-Vall d'Hebron Sexually Transmitted Infections Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain.
Alcoceba E; Microbiology Department, Son Espases Hospital Universitari, Mallorca, Spain.
Romero B; Microbiology Department, Ramón y Cajal Hospital Universitario, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Menéndez B; Sexually Transmitted Infections Study Group (GEITS), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.; Sandoval Health Centre, San Carlos Hospital Clínico, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Bernal S; Sexually Transmitted Infections Study Group (GEITS), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.; Microbiology Department, Virgen de Valme Hospital Universitario, Sevilla, Spain.
Idigoras P; Microbiology Department, Donostia Hospital Universitario, San Sebastián, Spain.
Colomina J; Microbiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Martin-Saco G; Sexually Transmitted Infections Study Group (GEITS), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.; Microbiology Department, Miguel Servet Hospital Universitario, Zaragoza, Spain.
Leal-Negredo Á; Sexually Transmitted Infections Study Group (GEITS), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.; Microbiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Torreblanca A; Sexually Transmitted Infections Study Group (GEITS), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.; Microbiology Department, Cabueñes Hospital Universitario, Gijón, Spain.
Martínez O; Microbiology Department, La Ribera Hospital Universitario, Valencia, Spain.
Serra-Pladevall J; Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Sexually Transmitted Infections Study Group (GEITS), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.; Department of Genetics and Microbiology, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Impact of extracorporeal membrane oxygenation (ECMO) support on piperacillin exposure in septic patients: a case-control study.
Autorzy :: Fillâtre P; St Brieuc Hospital, Réanimation Polyvalente, F-22000 St Brieuc, France.
Lemaitre F; Univ Rennes, Rennes University Hospital, Inserm, EHESP, Irset (Institut de Recherche en santé, Environnement et Travail) - UMR_S 1085, F-35000 Rennes, France.
Nesseler N; Rennes University Hospital, Service de Réanimation de Chirurgie Cardiothoracique et de Chirurgie Vasculaire, F-35000 Rennes, France.; Univ Rennes, Inra, Inserm, Institut NUMECAN - UMR_A 1341, UMR_S 1241, CIC 1414, F35000 Rennes, France.
Schmidt M; Sorbonne Université, Institute of Cardiometabolism and Nutrition, APHP, Pitié-Salpêtrière Hospital, Medical Intensive Care Unit, Paris, France.
Besset S; Louis Mourier Hospital, Médecine Intensive-Réanimation, AP-HP, F92700 Colombes, France.
Launey Y; Univ Rennes, Inra, Inserm, Institut NUMECAN - UMR_A 1341, UMR_S 1241, CIC 1414, F35000 Rennes, France.; Rennes University Hospital, Surgical Critical Care Unit, Department of Anaesthesia, Critical Care and Perioperative Medicine, F-35033 Rennes, France.
Maamar A; Rennes University Hospital, Infectious Diseases and Intensive Care Unit, F-35033 Rennes, France.; Univ Rennes, Faculté de Médecine, Biosit, F-35043 Rennes, France.; Univ Rennes, Inserm-CIC-1414, IFR 140, F-35033 Rennes, France.
Daufresne P; Rennes University Hospital, Haematology Unit, F-35033 Rennes, France.
Flecher E; Rennes University Hospital, Department of Thoracic and Cardiovascular Surgery, F-35033 Rennes, France.; Univ Rennes, Inserm U1099, Signal and Image Treatment Laboratory (LTSI), F-35033 Rennes, France.
Le Tulzo Y; Rennes University Hospital, Infectious Diseases and Intensive Care Unit, F-35033 Rennes, France.; Univ Rennes, Faculté de Médecine, Biosit, F-35043 Rennes, France.; Univ Rennes, Inserm-CIC-1414, IFR 140, F-35033 Rennes, France.
Tadie JM; Rennes University Hospital, Infectious Diseases and Intensive Care Unit, F-35033 Rennes, France.; Univ Rennes, Faculté de Médecine, Biosit, F-35043 Rennes, France.; Univ Rennes, Inserm-CIC-1414, IFR 140, F-35033 Rennes, France.
Tattevin P; Rennes University Hospital, Infectious Diseases and Intensive Care Unit, F-35033 Rennes, France.; Univ Rennes, Faculté de Médecine, Biosit, F-35043 Rennes, France.; Univ Rennes, Inserm-CIC-1414, IFR 140, F-35033 Rennes, France.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Identification of a novel tetracycline resistance gene, tet(63), located on a multiresistance plasmid from Staphylococcus aureus.
Autorzy :: Zhu Y; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Wang C; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Schwarz S; Institute of Microbiology and Epizootics, Centre for Infection Medicine, Department of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Liu W; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Yang Q; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Luan T; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Wang L; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Liu S; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Zhang W; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 576-581.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Efficacy of dual carbapenem treatment in a murine sepsis model of infection due to carbapenemase-producing Acinetobacter baumannii.
Autorzy :: Cebrero-Cangueiro T; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain.
Nordmann P; Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland.; INSERM European Unit (LEA-IAME, France), University of Fribourg, Fribourg, Switzerland.; National Reference Center for Emerging Antibiotic Resistance, University of Fribourg, Fribourg, Switzerland.; University of Lausanne and University Hospital Center, Lausanne, Switzerland.
Carretero-Ledesma M; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, Seville, Spain.; Clinical Unit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocio University Hospital, Seville, Spain.
Pachón J; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain.
Pachón-Ibáñez ME; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, Seville, Spain.; Clinical Unit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocio University Hospital, Seville, Spain.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 680-683.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines.
Autorzy :: Zhabokritsky A; Department of Medicine, University Health Network, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada.
Szadkowski L; Department of Medicine, University Health Network, Toronto, Canada.; Biostatistics Research Unit, University Health Network, Toronto, Canada.
Cooper C; Department of Medicine, University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
Loutfy M; Department of Medicine, University of Toronto, Toronto, Canada.; Women's College Research Institute, Women's College Hospital, Toronto, Canada.
Wong A; Department of Medicine, University of Saskatchewan, Regina, Canada.
McClean A; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Hogg RS; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Walmsley SL; Department of Medicine, University Health Network, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.; Pokaż więcej
Corporate Authors :: Canadian Observational Cohort (CANOC) Collaboration
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 729-737.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
Autorzy :: Weiner M; University of Texas Health Science Center San Antonio, San Antonio, TX, USA.; South Texas Veterans Health Care System, San Antonio, TX, USA.
Gelfond J; University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
Johnson-Pais TL; University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
Engle M; University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
Johnson JL; Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.; Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda.
Whitworth WC; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Bliven-Sizemore E; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Nsubuga P; Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda.
Dorman SE; Medical University of South Carolina, Charleston, SC, USA.
Savic R; University of California San Francisco, San Francisco, CA, USA.; Pokaż więcej
Corporate Authors :: Pharmacokinetics/Pharmacodynamics Group of Tuberculosis Trials Consortium
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 582-586.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.
Autorzy :: Revollo B; Division of Infectious Diseases and FLS Foundation for Fighting AIDS, Infectious Diseases and Promoting Health and Science, University Hospital Germans Trias, Badalona, Spain.
Tebe C; Biostatistics Unit, Bellvitge Biomedical Research Institute (IDIBELL)/University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
Peñafiel J; Biostatistics Unit, Bellvitge Biomedical Research Institute (IDIBELL)/University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
Blanco I; Metropolitana Nord Laboratory, Institut Català de la Salut, Badalona, Spain.
Perez-Alvarez N; Division of Infectious Diseases and FLS Foundation for Fighting AIDS, Infectious Diseases and Promoting Health and Science, University Hospital Germans Trias, Badalona, Spain.; Statistics and Operations Research Department, Universitat Politècnica de Catalunya-Barcelona Tech, Barcelona, Spain.
Lopez R; Occupational Risk Prevention Unit, University Hospital Germans Trias, Badalona, Spain.
Rodriguez L; Pulmonary Medicine, University Hospital Germans Trias, Badalona, Spain.
Ferrer J; Internal Medicine Department, University Hospital Germans Trias, Badalona, Spain.
Ricart P; Intensive Care Unit Division, University Hospital Germans Trias, Badalona, Spain.
Moret E; Anaesthesiology Department, University Hospital Germans Trias, Badalona, Spain.
Tural C; Internal Medicine Department, University Hospital Germans Trias, Badalona, Spain.
Carreres A; Emergency Department, University Hospital Germans Trias, Badalona, Spain.
Matllo J; Occupational Risk Prevention Unit, University Hospital Germans Trias, Badalona, Spain.
Videla S; Division of Infectious Diseases and FLS Foundation for Fighting AIDS, Infectious Diseases and Promoting Health and Science, University Hospital Germans Trias, Badalona, Spain.; Clinical Research Support Unit, Clinical Pharmacology Department, Bellvitge University Hospital/Bellvitge Biomedical Research Institute (IDIBELL)/University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
Clotet B; Division of Infectious Diseases and FLS Foundation for Fighting AIDS, Infectious Diseases and Promoting Health and Science, University Hospital Germans Trias, Badalona, Spain.; Universitat de Vic-Universitat Central de Catalunya (UVIC-UCC), Vic, Spain.; Universitat Autònoma de Barcelona, Bellaterra, Spain.
Llibre JM; Division of Infectious Diseases and FLS Foundation for Fighting AIDS, Infectious Diseases and Promoting Health and Science, University Hospital Germans Trias, Badalona, Spain.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 827-829.
Typ publikacji :: Letter; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19/*diagnosis
Health Personnel/*trends
Hydroxychloroquine/*administration & dosage
Pre-Exposure Prophylaxis/*trends
Antimalarials/administration & dosage ; COVID-19/blood ; COVID-19/prevention & control ; Case-Control Studies ; Cross-Sectional Studies ; Humans ; Pre-Exposure Prophylaxis/methods
: Raport

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART.
Autorzy :: Rawizza HE; Brigham and Women's Hospital, Boston, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Oladokun R; College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria.
Ejeliogu E; College of Health Sciences, Jos University Teaching Hospital, University of Jos, Jos, Nigeria.
Oguche S; College of Health Sciences, Jos University Teaching Hospital, University of Jos, Jos, Nigeria.
Ogunbosi BO; College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria.
Agbaji O; College of Health Sciences, Jos University Teaching Hospital, University of Jos, Jos, Nigeria.
Odaibo G; College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria.
Imade G; College of Health Sciences, Jos University Teaching Hospital, University of Jos, Jos, Nigeria.
Olaleye D; College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria.
Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Darin KM; Northwestern University School of Professional Studies, Chicago, IL, USA.
Okonkwo P; APIN Public Health Initiatives Ltd/Gte, Abuja, Nigeria.
Kanki PJ; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Scarsi KK; College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA.
McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 710-717.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Knowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients.
Autorzy :: Colombo AL; Department of Medicine, Division of Infectious Diseases, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Agnelli C; Department of Medicine, Division of Infectious Diseases, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Kontoyiannis DP; Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pokaż więcej
Źródło :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 543-546.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] NLMUID: 7513617"" wg kryterium: JN

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Język